Fractures and Bone Mineral Density in Adult Women with 21-Hydroxylase Deficiency
The DOI matches its Crossref record; 39 of the 42 references it cites were found in a registry or an index.
Abstract
CONTEXT: Patients with classical congenital adrenal hyperplasia (CAH) receive lifelong, often supraphysiological, glucocorticoid therapy. Pharmacological doses of glucocorticoids are an established risk factor for osteoporosis. OBJECTIVE: Our objective was to evaluate bone mineral density (BMD), fracture prevalence, and markers of bone metabolism in adult females with CAH. DESIGN: This was a cross-sectional observational study. SETTING: Tertiary care referral centers were used in this study. PARTICIPANTS: We studied 61 women, aged 18-63 yr, with genetically verified CAH due to 21-hydroxylase deficiency. They were patients with salt wasting (n = 27), simple virilizing (n = 28), and nonclassical 21-hydroxylase deficiency (n = 6). A total of 61 age-matched women were controls. MAIN OUTCOME MEASURES: History of fractures was recorded. Total body, lumbar spine, and femoral neck BMD were measured by dual-energy x-ray absorptiometry. The World Health Organization criteria for osteopenia and osteoporosis were used. Serum marker of bone resorption, beta-C telopeptide was studied. RESULTS: The mean glucocorticoid dose in hydrocortisone equivalents was 16.9 +/- 0.9 mg/m2. Patients had lower BMD than controls at all measured sites (P < 0.001). In patients younger than 30 yr old, 48% were osteopenic vs. 12% in controls (P < 0.009). In patients 30 yr or older, 73% were osteopenic or osteoporotic vs. 21% in controls (P < 0.001). BMD was similar in the two classical forms and had no obvious relationship to genotypes. beta-C-telopeptide was decreased in older patients. More fractures were reported in patients than controls (P < 0.001). The number of vertebrae and wrist fractures almost reached significance (P = 0.058). CONCLUSIONS: Women with CAH have low BMD and increased fracture risk. BMD should be monitored, adequate prophylaxis and treatment instituted, and glucocorticoid doses optimized from puberty.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Using the WHO definition of reduced BMD 16, the prevalence of reduced BMD in previous CAH studies ranges between 45–60% 3, 4, 17 as compared to 52% in our cohort.”
From Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (2015) · cites this paper as [4]
In the citing paper
“In contrast, a retrospective study of 62 adult women with CAH reported that chronic exposure to pharmacological GC doses may lead to bone loss accompanied by an increased incidence of fractures relative to healthy controls (264).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [264]
In the citing paper
“Bone density (total and medullary cross-sectional area) is increased in women with CAH with variably elevated serum testosterone (including into the male range) when it is only partially suppressed by glucocorticoid treatment (143), although more effective glucocorticoid suppression lowers bone density (144).”
From Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance (2018) · cites this paper as [144]
Citations
Cites
Mazess, R., Barden, H., Bisek, J., & Hanson, J. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.6.1106 · Cited by 1,476 · cited 1×
“Whole body, lumbar spine (L2–L4), femoral neck BMD, body fat, and lean body mass were estimated by dual-energy x-ray absorptiometry (DXA) in 57 patients and 60 control subjects using a Lunar Model DPX-L or Prodigy equipment (Lunar Radiation, Madison, WI) using a standard procedure as previously described (23).”
MethodCongenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
New approaches for interpreting projected bone densitometry data
Professor Carter, D. R., Bouxsein, M. L., & Marcus, R. (1992) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650070204 · Cited by 1,065
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Clinical and Anthropometric Correlates of Bone Mineral Acquisition in Healthy Adolescent Girls*
KATZMAN, D. K., BACHRACH, L. K., CARTER, D. R., & MARCUS, R. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-6-1332 · Cited by 734 · cited 1×
“(26) to whole body measurements: BMAD BMC/(bone area(2): height).”
BackgroundCongenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
International Variations in Hip Fracture Probabilities: Implications for Risk Assessment
Kanis, J. A., Johnell, O., De Laet, C., Jonsson, B., Oden, A., & Ogelsby, A. K. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.7.1237 · Cited by 605
(2002) · Hormone Research in Paediatrics · doi:10.1159/000065490 · Cited by 458
Congenital Adrenal Hyperplasia: Is there an Effect on Penile Growth?
Levy, J. B., & Husmann, D. A. (1996) · The Journal of Urology · doi:10.1097/00005392-199608001-00060 · Cited by 415
Rudolph, A. M., Hoffman, J. I. E., & Rudolph, C. D. (1991) · Medical Entomology and Zoology · Cited by 336
Joint LWPES/ESPE CAH Working Group (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020611 · Cited by 332
Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321
Bang, P., Eriksson, U., Sara, V., Wivall, I.-L., & Hall, K. (1991) · Acta Endocrinologica · doi:10.1530/acta.0.1240620 · Cited by 308
Perspectives on glucocorticoid-induced osteoporosis
Canalis, E., Bilezikian, J. P., Angeli, A., & Giustina, A. (2004) · Bone · doi:10.1016/j.bone.2003.11.026 · Cited by 249
Hilding, A., Hall, K., Wivall-Helleryd, I.-L., Sääf, M., Melin, A.-L., & Thorén, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5793 · Cited by 182
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167 · cited 3×
“Our patients were treated with supraphysiological glucocorticoid doses as the androgens were markedly suppressed (6).”
BackgroundSelf-citationGirgis, R., & Winter, J. S. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4320 · Cited by 139
Stikkelbroeck, N. M. M. L., Oyen, W. J. G., van der Wilt, G.-J., Hermus, A. R. M. M., & Otten, B. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021074 · Cited by 138 · cited 6×
“4646 J Clin Endocrinol Metab, December 2007, 92(12):4643–4649 Falhammar et al.”
BackgroundResultInfluentialCongenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issues
Ogilvie, C. M., Crouch, N. S., Rumsby, G., Creighton, S. M., Liao, L., & Con Way, G. S. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02410.x · Cited by 136
Osteoporosis Associated with Excess Glucocorticoids
Shaker, J. L., & Lukert, B. P. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.014 · Cited by 116
Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron, F. J., Kaymakci, B., Byrt, E. A., Ebeling, P. R., Warne, G. L., & Wark, J. D. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.7.7608286 · Cited by 114
Hagenfeldt, K., Martin Ritzen, E., Ringertz, H., Helleday, J., & Carlstrom, K. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430667 · Cited by 110
Self-citationKing, J. A., Wisniewski, A. B., Bankowski, B. J., Carson, K. A., Zacur, H. A., & Migeon, C. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0745 · Cited by 104 · cited 2×
“Our results are in accordance with those of four previous studies with a smaller number of women with CAH (16, 17, 19, 20).”
ResultBone density in young patients with congenital adrenal hyperplasia
Mora, S., Saggion, F., Russo, G., Weber, G., Bellini, A., Prinster, C., & Chiumello, G. (1996) · Bone · doi:10.1016/8756-3282(96)00003-8 · Cited by 95
Jääskeläinen, J., & Voutilainen, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.8620871.x · Cited by 92 · cited 2×
“Thus, the reason why adult women with CAH are osteopenic/osteoporotic is probably lifetime exposure to glucocorticoids, which we (17) and others have previously shown (16).”
BackgroundResultGussinyé, M., Carrascosa, A., Potau, N., Enrubia, M., Vicens-Calvet, E., Ibáñez, L., & Yeste, D. (1997) · PEDIATRICS · doi:10.1542/peds.100.4.671 · Cited by 90
Height, Bone Mineral Density and Bone Markers in Congenital Adrenal Hyperplasia
Paganini, C., Radetti, G., Livieri, C., Braga, V., Migliavacca, D., & Adami, S. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053253 · Cited by 87
Sciannamblo, M., Russo, G., Cuccato, D., Chiumello, G., & Mora, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2823 · Cited by 82 · cited 3×
“Our results are in accordance with those of four previous studies with a smaller number of women with CAH (16, 17, 19, 20).”
BackgroundResultClinical pharmacology of the anti‐inflammatory steroids
Liddie, G. W. (1961) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt196125615 · Cited by 81
Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia
Guo, C., Weetman, A. P., & Eastell, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00851.x · Cited by 79
Christiansen, P., Mølgaard, C., & Müller, J. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075588 · Cited by 61 · cited 1×
“The two studies not entirely in accordance with the present have been small (eight and 15 females, respectively) and did not include older women, which might explain the differences (12, 13).”
ResultBang, P., Degerblad, M., Thorén, M., Schwander, J., Blum, W., & Hall, K. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280397 · Cited by 55
Novel Mutations in CYP21 Detected in Individuals with Hyperandrogenism
Lajic, S. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2824 · Cited by 51
Effect of Short-Term Prednisone Use on Blood Flow, Muscle Protein Metabolism, and Function
Short, K. R., Nygren, J., Bigelow, M. L., & Nair, K. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0908 · Cited by 50 · cited 2×
“With high-dose GH treatment, this resistance can be overcome, and growth rate increases (36).”
BackgroundArisaka, O., Hoshi, M., Kanazawa, S., Numata, M., Nakajima, D., Kanno, S., Negishi, M., Nishikura, K., Nitta, A., Imataka, M., et al. (2001) · Metabolism · doi:10.1053/meta.2001.21678 · Cited by 50 · cited 1×
“served normal (7–13), some elevated (14, 15), and some deFirst Published Online September 18, 2007 Abbreviations: ALP, Alkaline phosphatase; BMAD, bone mineral apparent density; BMC, bone mineral content; BMD, bone mineral density; CAH, congenital adrenal hyperplasia; CTX, -C-telopeptide of type I collagen; DHEAS, deh…”
BackgroundFalhammar, H., & Thoren, M. (2005) · Journal of Endocrinological Investigation · doi:10.1007/bf03347226 · Cited by 23 · cited 1×
“Furthermore, a significant number of patients with the milder nonclassical (NC) form, which often presents with hyperandrogenism later in life, require glucocorticoid therapy (2, 3).”
BackgroundSelf-citationZhou, X. J., Ky, L., Pillai, C. C., How, H., Yap, H., & Lee, K. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440237 · Cited by 20
INCREASED BONE MINERAL DENSITY IN CONGENITAL ADRENAL HYPERPLASIA (CAH)
Speiser, P., New, M. I., & Gertner, J. M. (1993) · Pediatric Research · doi:10.1203/00006450-199305001-00467 · Cited by 15
[Clinical pharmacology of anti-inflammatory steroids].
Salvá, J. A. (1970) · PubMed · Cited by 7
Cited by
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
“Longterm observational studies have been somewhat informative (227, 228, 230, 231).”
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
Handelsman, D. J., Hirschberg, A. L., & Bermon, S. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00020 · Cited by 594
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citation
Metadata
- Authors
- Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M.
- Affiliations
- Karolinska University Hospital (SE)
- Departments of Endocrinology (H.Fi.), Sahlgrenska University Hospital and Sahlgrenska Academy, SE-413 45 Gothenburg, Sweden
- Sahlgrenska University Hospital (SE)
- Departments of Paediatric Surgery (A.N.), Karolinska University Hospital and Karolinska Institute, SE-171 76 Stockholm, Sweden
- Departments of Molecular Medicine and Surgery (H.Fa., A.N., M.T.), Karolinska University Hospital and Karolinska Institute, SE-171 76 Stockholm, Sweden
- Corresponding author
- Falhammar, Henrik
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2007-12-01
- Volume
- 92
- Issue
- 12
- Pages
- 4643-4649
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2095652975
- Cited by
- 151
- References
- 42
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 2 · 2023: 10 · 2022: 7 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 11 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 11 · 2013: 7 · 2012: 9
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Göteborgs Läkaresällskap
- Magnus Bergvalls Stiftelse
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- 21-hydroxylase deficiency, congenital adrenal hyperplasia, bone mineral density, fracture, osteoporosis, osteopenia, glucocorticoid therapy, cortisol, bone resorption, women, salt wasting, fracture risk
- MeSH terms
- Adrenal Hyperplasia, Congenital, Adult, Bone and Bones, Female, Genotype, Glucocorticoids, Hormones, Humans, Mutation, Osteoporosis, Parathyroid Hormone, Steroid 21-Hydroxylase, Cohort Studies, Biomarkers, Bone Density, Collagen Type I, Fractures, Bone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.